{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"familial-hypobetalipoproteinemia-1","columns":[{"gene":"","key":"population-8070602b34c1c307979f","label":"Hypobetalipoproteinemia, familial, 1","mondoId":"MONDO:0014252","onsetQualifier":null,"originColumnKey":"MONDO:0014252/OMIM:615558","originalViews":[{"key":"MONDO:0014252/OMIM:615558","label":"Hypobetalipoproteinemia, familial, 1","scopeLabel":"OMIM:615558","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["01e24dc060cf10916d150badcdc2c1bfde99849306f0b33df5d214c5aff7ce07","23481b66933254dad7cb10a59ee91b14924ff457bc1d00f6ac723f22752cbdc9","2c8939e6638be5346b739e40b4a0baf8c7f75e8989e69a0911ebf7cfc7fa1c54","4440ee578304f21c6e1d29df64c34cbab99eafb7f3f2329563a919bc31b8925c","470342e20db65648150494f95f4098cd9701cb70ecf25af2f7200319353ab656","5921d9b1acbe5dff9890dd324eaaca8500db4899a6d9cc78bc4e17ad5aa6b6a4","5db8f9a741da30b2a2a60c1456db3c7763f69eab576d265806dbcacc36f8f8a4","5f6e951e6d2d18fcb2090c4f4865623e070c1fc084f708052f5fe61c0c067199","88c2ee5bc735d3728f224e19e91b7e3e6563413b05657369f2a70b8c5e5b7010","95ec61ec80e11b625048699d1bfc2f33367051883be01c05366e840de4538f62","daea321821b2815fed450f8071da5f60c4b170adba25588ed369d096372278d9","ed267f5f1ac1f7d97372791a4d1bb26b5337ec8a55f302a742efdef4c63ad743","f0a0acfd1e575a9ad75d0940965c8c8161547baedd317c1f5c07c4e1eda96445","f9a6750f7afdd8c7906bc4844ba117dc57cbe05550d126a5a43e90fb0dbd47c3"],"recordQualifiers":{},"scopeLabel":"OMIM:615558","sourceIds":["OMIM:615558"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-8070602b34c1c307979f"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001927","HP:0001251","HP:0003233","HP:0003563","HP:0100513","HP:0001315","HP:0031964"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":14,"sourceGroups":{"omim":3,"published":11}},"features":[{"hpoId":"HP:0001927","label":"Acanthocytosis","primary":true},{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0003233","label":"Decreased circulating HDL-C concentration","primary":true},{"hpoId":"HP:0003563","label":"Decreased circulating LDL-C concentration","primary":true},{"hpoId":"HP:0100513","label":"Decreased circulating vitamin E concentration","primary":true},{"hpoId":"HP:0001315","label":"Diminished deep tendon reflex","primary":true},{"hpoId":"HP:0031964","label":"Elevated circulating alanine aminotransferase concentration","primary":true},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":false},{"hpoId":"HP:0002155","label":"Hypertriglyceridemia","primary":false},{"hpoId":"HP:0003146","label":"Hypocholesterolemia","primary":false},{"hpoId":"HP:0004905","label":"Reduced circulating vitamin A concentration","primary":false},{"hpoId":"HP:0000546","label":"Retinal degeneration","primary":false},{"hpoId":"HP:0000510","label":"Rod-cone dystrophy","primary":false},{"hpoId":"HP:0002570","label":"Steatorrhea","primary":false}],"ledeHtml":"Hypobetalipoproteinemia, familial, 1 is a disorder that impairs the body&#x27;s ability to absorb and transport fats, causing low levels of cholesterol in the blood. The severity of the condition varies widely. Mildly affected people may have no signs or symptoms. Many affected people develop an abnormal buildup of fats in the liver (called hepatic steatosis, or fatty liver). In severe cases, this may progress to cirrhosis. Some people also have digestive problems in childhood, resulting in failure to thrive. Hypobetalipoproteinemia, familial, 1 is usually caused by genetic changes in the APOB gene. In a few cases, it may be caused by genetic changes in other genes, or the cause may be unknown. It is inherited in an autosomal codominant manner; a genetic change in one copy of the APOB gene can cause the condition, but changes in both copies of the gene cause more severe symptoms.","mondoId":"MONDO:0014252","node":{"canonicalSlug":"familial-hypobetalipoproteinemia-1","comparisons":[{"documentSha256":"cedc3cf5a8ce1eef153217fbe1982fbc5725951b3814898e681a56afb1aaa69a","key":"legacy-familial-hypobetalipoproteinemia-1","kind":"legacy","label":"familial hypobetalipoproteinemia 1","memberIds":["MONDO:0014252"],"mondoId":"MONDO:0014252","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/familial-hypobetalipoproteinemia-1.cedc3cf5a8ce1eef153217fbe1982fbc5725951b3814898e681a56afb1aaa69a.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Familial hypobetalipoproteinemia 1","originalSourceId":"OMIM:615558","paragraphs":["Hypobetalipoproteinemia, familial, 1 is a disorder that impairs the body's ability to absorb and transport fats, causing low levels of cholesterol in the blood. The severity of the condition varies widely. Mildly affected people may have no signs or symptoms. Many affected people develop an abnormal buildup of fats in the liver (called hepatic steatosis, or fatty liver). In severe cases, this may progress to cirrhosis. Some people also have digestive problems in childhood, resulting in failure to thrive. Hypobetalipoproteinemia, familial, 1 is usually caused by genetic changes in the APOB gene. In a few cases, it may be caused by genetic changes in other genes, or the cause may be unknown. It is inherited in an autosomal codominant manner; a genetic change in one copy of the APOB gene can cause the condition, but changes in both copies of the gene cause more severe symptoms."],"rawAttribution":"MONDO:0014252","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:16Z","upstream":"GARD:0002876","url":"https://rarediseases.info.nih.gov/diseases/2876"},"ownColumnKeys":["population-8070602b34c1c307979f"],"publication":"published","relationships":[{"kind":"parent","label":"hypobetalipoproteinemia","mondoId":"MONDO:0017774","slug":"hypobetalipoproteinemia"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"multiple-identity-targets","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/familial-hypobetalipoproteinemia"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"01e24dc060cf10916d150badcdc2c1bfde99849306f0b33df5d214c5aff7ce07","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0003233","is_excluded":false,"label":"Decreased circulating HDL-C concentration","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"23481b66933254dad7cb10a59ee91b14924ff457bc1d00f6ac723f22752cbdc9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"OMIM:615558","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"2c8939e6638be5346b739e40b4a0baf8c7f75e8989e69a0911ebf7cfc7fa1c54","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0001927","is_excluded":false,"label":"Acanthocytosis","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"4440ee578304f21c6e1d29df64c34cbab99eafb7f3f2329563a919bc31b8925c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001315","is_excluded":false,"label":"Diminished deep tendon reflex","onset_id":null,"reference":"OMIM:615558","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"470342e20db65648150494f95f4098cd9701cb70ecf25af2f7200319353ab656","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0000546","is_excluded":false,"label":"Retinal degeneration","onset_id":null,"reference":"OMIM:615558","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5921d9b1acbe5dff9890dd324eaaca8500db4899a6d9cc78bc4e17ad5aa6b6a4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0003146","is_excluded":false,"label":"Hypocholesterolemia","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5db8f9a741da30b2a2a60c1456db3c7763f69eab576d265806dbcacc36f8f8a4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0004905","is_excluded":false,"label":"Reduced circulating vitamin A concentration","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5f6e951e6d2d18fcb2090c4f4865623e070c1fc084f708052f5fe61c0c067199","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0002570","is_excluded":false,"label":"Steatorrhea","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"88c2ee5bc735d3728f224e19e91b7e3e6563413b05657369f2a70b8c5e5b7010","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"95ec61ec80e11b625048699d1bfc2f33367051883be01c05366e840de4538f62","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0002155","is_excluded":true,"label":"Hypertriglyceridemia","onset_id":null,"reference":"PMID:1939657","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"daea321821b2815fed450f8071da5f60c4b170adba25588ed369d096372278d9","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"4/4","hpo_id":"HP:0003563","is_excluded":false,"label":"Decreased circulating LDL-C concentration","onset_id":null,"reference":"PMID:21981844;PMID:1939657","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"ed267f5f1ac1f7d97372791a4d1bb26b5337ec8a55f302a742efdef4c63ad743","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0000510","is_excluded":true,"label":"Rod-cone dystrophy","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f0a0acfd1e575a9ad75d0940965c8c8161547baedd317c1f5c07c4e1eda96445","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0100513","is_excluded":false,"label":"Decreased circulating vitamin E concentration","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f9a6750f7afdd8c7906bc4844ba117dc57cbe05550d126a5a43e90fb0dbd47c3","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:615558","disease_name":"Hypobetalipoproteinemia, familial, 1","evidence":"PCS","frequency_raw":"3/3","hpo_id":"HP:0031964","is_excluded":false,"label":"Elevated circulating alanine aminotransferase concentration","onset_id":null,"reference":"PMID:21981844","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2876\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0014252\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>GARD:0002876</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Hypobetalipoproteinemia, familial, 1 is a disorder that impairs the body&#x27;s ability to absorb and transport fats, causing low levels of cholesterol in the blood. The severity of the condition varies widely. Mildly affected people may have no signs or symptoms. Many affected people develop an abnormal buildup of fats in the liver (called hepatic steatosis, or fatty liver). In severe cases, this may progress to cirrhosis. Some people also have digestive problems in childhood, resulting in failure to thrive. Hypobetalipoproteinemia, familial, 1 is usually caused by genetic changes in the APOB gene. In a few cases, it may be caused by genetic changes in other genes, or the cause may be unknown. It is inherited in an autosomal codominant manner; a genetic change in one copy of the APOB gene can cause the condition, but changes in both copies of the gene cause more severe symptoms.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/2876\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"familial-hypobetalipoproteinemia-1","sourceDocuments":[{"name":"GARD: Familial hypobetalipoproteinemia 1","reviewed":null,"source_release":"2026-10-21T17:04:16Z","url":"https://rarediseases.info.nih.gov/diseases/2876"},{"name":"MONDO: familial hypobetalipoproteinemia 1","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0014252"}],"sourceNote":"","synonyms":["APOB hypobetalipoproteinemia","familial hypobetalipoproteinemia 1","familial hypobetalipoproteinemia type 1","FHBL","FHBL1","hypobetalipoproteinemia caused by mutation in APOB","hypobetalipoproteinemia, familial, 1","hypobetalipoproteinemia, familial, type 1"],"takeawayHtml":"","title":"familial hypobetalipoproteinemia 1"},"schemaVersion":1}
